Form D Explorer
Consano Bio, Inc. · CIK 1981285

Report a data issueCitable research briefCompare issuerPrivate research collection

Consano Bio, Inc.

CIK 1981285 · Corporation · Inc. DELAWARE · BURLINGTON, Massachusetts · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Dec 12, 2025
through Mar 20, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldDec 12, 2025 · DMar 20, 2026 · DLater minus earlier
Reported offering amount$16,840,000$48,858,795$32,018,795
Reported amount sold$16,840,000$34,824,466$17,984,466
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001981285-25-000005 · Later SEC source: 0001981285-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Mar 20, 2026

Reported offering amount
$48,858,795
Reported exemptions
Rule 506(b)
Reported amount sold
$34,824,466

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)